Find Research Outputs

Search in all content

Filters for Publications

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2018
  • 2017
  • 2016

Author

  • Yumei Ye
2018

Expression Profiling of Circular RNAs and Micrornas in Heart Tissue of Mice with Alcoholic Cardiomyopathy

Yang, Y., Chen, H., Ding, N., Wang, S., Duan, Z., Birnbaum, Y., Ye, Y. & Qian, J., May 1 2018, In : Cellular Physiology and Biochemistry. 46, 6, p. 2284-2296 13 p.

Research output: Contribution to journalArticle

4 Scopus citations

Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes

Birnbaum, Y., Bajaj, M., Yang, H. C. & Ye, Y., Mar 5 2018, (Accepted/In press) In : Cardiovascular Drugs and Therapy. p. 1-11 11 p.

Research output: Contribution to journalArticle

26 Scopus citations

Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine

Yang, X., Chen, H., Chen, Y., Birnbaum, Y., Liang, R., Ye, Y. & Qian, J., Oct 1 2018, In : Cellular Physiology and Biochemistry. 50, 2, p. 569-584 16 p.

Research output: Contribution to journalArticle

1 Scopus citations

GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials

Jia, X., Alam, M., Ye, Y., Bajaj, M. & Birnbaum, Y., Feb 14 2018, (Accepted/In press) In : Cardiovascular Drugs and Therapy. p. 1-8 8 p.

Research output: Contribution to journalArticle

15 Scopus citations
2020

Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay

Chen, H., Tran, D., Yang, H. C., Nylander, S., Birnbaum, Y. & Ye, Y., Aug 1 2020, In : Cardiovascular Drugs and Therapy. 34, 4, p. 443-461 19 p.

Research output: Contribution to journalArticle

1 Scopus citations
2016

Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine

Birnbaum, Y., Birnbaum, G. D., Birnbaum, I., Nylander, S. & Ye, Y., Dec 1 2016, In : Cardiovascular Drugs and Therapy. 30, 6, p. 539-550 12 p.

Research output: Contribution to journalArticle

19 Scopus citations

Type 2 diabetes and cardiovascular disease: A metabolic overview of recent clinical trials

Birnbaum, Y., Ye, Y. & Bajaj, M., 2016, (Accepted/In press) In : Journal of Diabetes and its Complications.

Research output: Contribution to journalArticle

1 Scopus citations
2017

Unraveling the Interaction of Aspirin, Ticagrelor, and Rosuvastatin on the Progression of Atherosclerosis and Inflammation in Diabetic Mice

Ye, Y., Nylander, S. & Birnbaum, Y., Nov 28 2017, (Accepted/In press) In : Cardiovascular Drugs and Therapy. p. 1-12 12 p.

Research output: Contribution to journalArticle

7 Scopus citations
2018

Size matters in STEMI: time for translation of ticagrelor?

Birnbaum, Y. & Ye, Y., Dec 1 2018, In : Cardiovascular Research. 114, 14, p. 1817-1818 2 p.

Research output: Contribution to journalArticle

2016

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

Birnbaum, Y., Bajaj, M., Qian, J. & Ye, Y., Aug 1 2016, In : BMJ Open Diabetes Research and Care. 4, 1, e000227.

Research output: Contribution to journalArticle

35 Scopus citations
2020

Does Inhibition of Nuclear Factor Kappa B Explain the Protective Effect of Ticagrelor on Myocardial Ischemia-Reperfusion Injury?

Birnbaum, Y., Ye, Y. & Perez-Polo, J. R., Feb 1 2020, In : Journal of cardiovascular pharmacology. 75, 2, p. 108-111 4 p.

Research output: Contribution to journalArticle

2017
72 Scopus citations
2018

Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation

Ye, Y., Jia, X., Bajaj, M. & Birnbaum, Y., Jan 1 2018, (Accepted/In press) In : Cardiovascular Drugs and Therapy.

Research output: Contribution to journalArticle

14 Scopus citations
2016

Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury

Qian, J., Chen, H., Birnbaum, Y., Nanhwan, M. K., Bajaj, M. & Ye, Y., Feb 10 2016, (Accepted/In press) In : Cardiovascular Drugs and Therapy. p. 1-13 13 p.

Research output: Contribution to journalArticle

7 Scopus citations
2017

Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ Agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia

Chen, Y., Chen, H., Birnbaum, Y., Nanhwan, M. K., Bajaj, M., Ye, Y. & Qian, J., Mar 1 2017, In : Diabetes and Vascular Disease Research. 14, 2, p. 152-162 11 p.

Research output: Contribution to journalArticle

3 Scopus citations
2020

Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy

Ye, Y., Birnbaum, Y., Widen, S., Zhang, Z., Zhu, S., Bajaj, M. & Chen, H., 2020, (Accepted/In press) In : Cardiovascular Drugs and Therapy.

Research output: Contribution to journalArticle

2018

SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials

Jia, X., Mehta, P. B., Ye, Y., Alam, M., Birnbaum, Y. & Bajaj, M., Sep 1 2018, In : Current Diabetes Reports. 18, 9, 63.

Research output: Contribution to journalReview article

4 Scopus citations